Meclizine Plasma Levels in Responders and Non-responders
NCT ID: NCT04482985
Last Updated: 2020-07-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
50 participants
INTERVENTIONAL
2020-09-01
2021-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Motion Sickness Medications and Vestibular Time Constant
NCT03270839
Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion Sickness
NCT04272255
Galvanic Vestibular Stimulation as a Novel Treatment for Seasickness
NCT05004818
Efficacy of Metoclopramide in Poor Ovarian Response IVF Patients
NCT03560583
Video Head Impulse Test and Seasickness Susceptibility
NCT05657340
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Meclizine responders
Meclizine Hydrochloride
Meclzine is given to all study participants to prevent seasickness. Meclizine plasma levels are determined from both the meclizine responders and non responders group.
Meclizine non responders
Meclizine Hydrochloride
Meclzine is given to all study participants to prevent seasickness. Meclizine plasma levels are determined from both the meclizine responders and non responders group.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Meclizine Hydrochloride
Meclzine is given to all study participants to prevent seasickness. Meclizine plasma levels are determined from both the meclizine responders and non responders group.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjective functioning at 1 meter sea voyage - 5/10 and lower.
* Subjects who were prescribed 25mg of meclizine.
* Subjects who did not take any other drugs 48 prior to their participation in the study.
Exclusion Criteria
* Vertigo complains
* Any ear infection
* Use of Scopolamine based anti-seasickness drugs.
* Use of meclizine 50mg.
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical Corps, Israel Defense Force
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yoni Gutkovich
deputy of the head of department for the human performance laboratory, the Israeli naval institute, Haifa.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Wang Z, Qian S, Zhang Q, Chow MS. Quantification of meclizine in human plasma by high performance liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Jan 1;879(1):95-9. doi: 10.1016/j.jchromb.2010.11.022. Epub 2010 Dec 1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.